Molekule is bringing its Air Mini+ and Air Pro air purifiers,
powered by patented PECO technology, to the UK and Europe for the first time
LONDON, Nov. 23, 2021 /PRNewswire/ -- Molekule, the
science company that reinvented air purification with its
groundbreaking PECO technology, today announced that its
award-winning air purifiers will be available to consumers in the
United Kingdom and across
Europe directly via Molekule's
website. Molekule's mission is to destroy indoor air pollution and
provide crisp, clean indoor air in homes, businesses, and beyond.
Starting today, Molekule's best selling air purifiers, Air Mini+
and Air Pro, will be available for purchase throughout the
region.
Molekule was founded in 2014 after 25 years of research and
development resulted in its innovative PECO technology, which sits
at the core of each and every Molekule purifier. Using PECO,
Molekule's air purifiers not only collect, but also destroy the
widest range of tiny pollutants when compared to traditional air
purifier technology; breaking down pollutants at molecular levels
such as allergens, mould, bacteria, viruses, and volatile organic
compounds (VOCs). Recent research from third party laboratories
show that Molekule destroys COVID-19 virus by over 99% in 1 hour in
small chamber and swatch lab tests[1], and
inactivates H1N1 flu virus by up to 99.99% in single pass
experiments[2]. Air Mini+ and Air Pro are
both cleared by the U.S. FDA for the destruction of bacteria and
viruses, and Air Pro is additionally cleared for the destruction of
mould.[3]
Many consumers are well aware of the dangers of outdoor air
pollution, specifically in metro areas across Europe. According to the European Environment
Agency, around 90% of people living in European cities are exposed
to pollutant concentrations that are higher than what is deemed
harmful to health.[4] What many consumers
aren't aware of is that indoor air can be just as polluted,
sometimes even more polluted, than the air we breathe
outdoors.[5] Molekule was founded
specifically to help address indoor air pollution, giving people
more control over the air they breathe in their daily lives.
Jonathan Harris, CEO at
Molekule comments: "The air we breathe day in and day out is
critical to our overall well-being. Our air purifiers are able to
destroy pollutants at microscopic levels – chemicals and
particles that we aren't even able to see – and leave behind
cleaner, safer indoor air. We've had our sights set on Europe for a long time and our team cannot
wait to introduce European customers to the power of PECO
technology."
As a science-based company, Molekule conducts extensive
testing of its technology internally as well as with
certified third-party laboratories. PECO technology has been
independently tested at the Intertek testing laboratory,
independent third-party testing laboratory ARE, University of Minnesota and with one of the world's
foremost research laboratories for indoor air quality, Lawrence
Berkeley National Laboratory (Berkeley).
Alongside its revolutionary approach to air purification,
Molekule's human-centered and contemporary design ensures that
its products are both beautiful and easy to use. The physical
design is thoughtful in form, material, size and
footprint, and its product design considerations are expressed down
to the finest detail. Consumers can control their Air Mini+ and Air
Pro purifiers and receive status updates on their air purifier's
filters via the Molekule app, on iOS and Android.
Headquartered in the US, Molekule now sells internationally in
the UK and Europe as well as
Canada, India, Japan
and Korea, bringing its unique air purification process to a
global market. In the UK and Europe, Molekule is launching its Air Pro
and Air Mini+ purifiers.
About Molekule
Molekule is on a mission to provide clean indoor air to
everyone, everywhere. Molekule was born
from the critical need to leverage science and innovation
to address the adverse impacts of polluted indoor air.
Based on 25 years of research and development, the company's
patented PECO technology destroys the widest range of pollutants,
including VOCs, mould, bacteria, viruses, and allergens, when
compared to conventional filters. Molekule's range of air
purification solutions have been reviewed and validated by
third-party laboratories, as well as continual internal testing,
and its medical-grade products have been granted medical device
clearance by the U.S. FDA. Molekule is headquartered in the US and
sells internationally in the UK, EU, Canada, India, Japan, and South Korea, bringing its unique air
purification process to a global customer base.
For more information, please
visit https://molekule.uk/ or https://molekule.eu/
Key Products
Air Mini+
The Air Mini+ is built for rooms up
to 23m2 (250 sq. ft.). Air Mini+ is an ideal
choice for apartment rooms, bedrooms, and home offices. It can
capture not only fine dust but also destroy a wide range of indoor
pollutants such as VOCs, bacteria, viruses, mould and allergens. A
particle sensor enables the purifier to sense particles in the air
and if on Auto Protect Mode, it will automatically adjust the fan
speed accordingly. Air Mini+ is also Apple HomeKit-enabled,
so users can control it using the Home app
on their iPad or iPhone.
UK
RRP: £449 inc VAT
EU
RRP: €499 inc VAT
Air Pro
Air Pro is Molekule's most advanced purifier, designed to destroy
pollutants such as VOCs, bacteria, viruses, mould and allergens in
extra-large spaces that are up to 93m2 (1000 sq. ft.). There are two
Auto Protect Modes that auto-adjust the airflow for particle
protection at noise levels (Standard and Quiet). Users can use the
touchscreen or the app to swipe and tap in order to see the device
info, filter status, or air particle levels.
UK
RRP: £1049 inc VAT
EU
RRP: €1199 inc VAT
[1] 2021 test results demonstrate
PECO air purification technology's success in removing 99.98% of
the COVID-19 virus SARS-CoV-2 from the air, and achieving total
destruction rates exceeding 99% after one hour. These results are
from a multiple pass chamber test and swatch level test,
respectively. The multiple pass chamber test utilized an Air Mini
device in a small 5.3 cubic-foot chamber with a single injection of
aerosolized virus, and the swatch level test used Molekule's
proprietary PECO-Filter media for direct virus application. Testing
conducted at the University of Nebraska
Medical Center, Department of Pharmacology &
Experimental Neuroscience. No air purifier can prevent transmission
of a virus and air purifiers are not a substitute for ventilation.
Molekule recommends use of ventilation, PPE & social distancing
and following directions of SAGE & other gov't
authorities. Actual results will depend on the environment
and in-room location that the air purifier is placed in and
real-world results may be less than those observed in the
laboratory tests.
[2] In 2020, the University of Minnesota College of Science and
Engineering and College of Veterinary Medicine tested Molekule's
PECO technology using an Air Mini purifier and its operating flow
rate in single-pass efficiency testing with viable viruses in
aerosol transmission. Methods developed for the research allowed
measurement and characterization of airborne virus detection and
inactivation by air purification technologies. For the PECO
technology, testing showed near 99.9% removal and total removal
rates (virus titer based) approaching 99.99% for influenza A after
four hours. Dr. Chris Hogan and Dr.
Montserrat Torremorell led this research.
[3] Although the U.S. FDA clearances
do not apply specifically to SARS-CoV-2, Molekule's devices satisfy
the criteria established in the U.S. FDA's non-enforcement guidance
for air purifier use in connection with SARS-CoV-2 during the
pandemic. Molekule devices are not intended for medical use
in the United Kingdom or
Europe and have not been cleared
as medical devices in those countries.
[4] "Air Pollution." European
Environment Agency, 23 Nov. 2020,
https://www.eea.europa.eu/themes/air/intro.
[5] U.S. Environmental Protection
Agency. 1987. The total exposure assessment methodology (TEAM)
study: Summary and analysis. EPA/600/6-87/002a. Washington, DC.
Photo -
https://mma.prnewswire.com/media/1693424/Molekule_Air_Mini.jpg
Photo -
https://mma.prnewswire.com/media/1693425/Molekule_Air_Pro.jpg
Photo -
https://mma.prnewswire.com/media/1693426/Molekule_Air_Pro.jpg
Photo - https://mma.prnewswire.com/media/1693427/Molekule.jpg
Logo -
https://mma.prnewswire.com/media/1693428/Molekule_Logo.jpg